Crowdsourcing for Value in Healthcare
Value-based healthcare is predicated on collaboration. Sharing of data, methods, pathways and perspectives among different stakeholders is paramount if the transition to value-based care is to be fully realized. Instead of relying solely on legacy methods to measure value, IVI’s Open-Source Value Platform (OSVP) uses a transparent and open-source process to develop methods and tools […]
Watch Mark Linthicum’s “101 Course” on IVI’s New Non-Small Cell Lung Cancer Value Model
IVI’s Director of Scientific Communications, Mark Linthicum, sits down with the Journal of Clinical Pathways for a webinar discussion about IVI’s open-source model for assessing value in non-small cell lung cancer therapies. If you want to learn more about IVI’s open-source approach to value assessment, this webinar is a great place to start. Click here to […]
IVI to Hold Two Public Webinars on New Open-Source Model for Non-Small Cell Lung Cancer
IVI will host two upcoming webinars focused on its new disease-specific, open-source value model to assess EGFR+ non-small cell lung cancer (NSCLC) therapy sequences. These webinars are free and open to the public. We hope you will join us to learn more about IVI’s Open-Source Value Project (OSVP) and the new IVI-NSCLC model. Detailed information and […]
How the Open Science Movement Creates Momentum for Value Assessment
In a Morning Consult commentary, IVI Executive Director, Jennifer Bright, discusses why transparency is a prerequisite to value-based reimbursement and how IVI’s Open-Source Value Platform (OSVP) is an open laboratory for creating sophisticated systems to assess value in healthcare. Read the full article here.
IVI’s Take on What’s In Store for Value Assessment in 2019
In an article published online by the American Journal of Managed Care, IVI’s Executive Director, Jennifer Bright, and Director of Scientific Communications, Mark Linthicum, offer five predictions for where value assessment is headed in 2019. Specifically, Jennifer and Mark focus their discussion on the following areas of interest regarding value assessment: Including patient perspectives becomes […]
Value Frameworks Must Incorporate Real-World Evidence, Says Research Team Including IVI’s Darius Lakdawalla and Wayne Burton
In a new paper published by the American Journal of Managed Care, a team of researchers, including IVI’s Darius Lakdawalla and Wayne Burton, conclude that key decision makers within our healthcare system need to recognize the importance of implementing real-world evidence and devote resources to further research into the chronic disease areas in which the […]
Journal of Clinical Pathways Podcast Focuses on Value
In an interview with the Journal of Clinical Pathways, IVI’s Jennifer Bright and Mark Linthicum discuss how IVI is transforming value assessment. Read the transcript from the interview here.
Patient Perspectives Must Meaningfully Inform Value Measurement
In an article published on AJMC.com, IVI’sJennifer Bright discusses how IVI makes incorporating patients’ perspectives a priority in developing open-source, transparent value models. Read the full article here.
IVI Highlighted in Article on Value Assessment in Oncology Treatments
In this month’s Drug Topics, correspondent Kathleen Gannon Longo speaks with Jeremy Schafer about the potentially tremendous impact that value assessments will have on future patient reimbursement decisions. Focusing on Oncology treatment, Schafer describes some of the existing value frameworks in play as well as referencing the work being done by the IVI to employ […]
Measuring Value: Jason Shafrin in The Journal of Healthcare Contracting
IVI Director of Research, Jason Shafrin, discusses the need for and mission of the IVI, as well as the keys to its success in the latest edition of The Journal of Healthcare Contracting. “If we find a research topic that life sciences, payers, providers are all behind and agree on — that’s a pretty powerful thing,” […]